Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates by Capone, S, Reyes-Sandoval, A, Naddeo, M, Siani, L, Ammendola, V, Rollier, C, Nicosia, A, Colloca, S, Cortese, R, Folgori, A, Hill, A

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates. by Capone, S, Reyes-Sandoval, A, Naddeo, M, Siani, L, Ammendola, V, Rollier, C, Nicosia, A, Colloca, S, Cortese, R, Folgori, A, Hill, A

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES by Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors e... by Goodman, A, Epp, C, Moss, D, Holder, A, Wilson, J, Gao, G, Long, C, Remarque, E, Thomas, A, Ammendola, V, Colloca, S, Dicks, MD, Biswas, S, Seibel, D, van Duivenvoorde, L, Gilbert, S, Hill, A, Draper, S

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors E... by Goodman, A, Epp, C, Moss, D, Holder, A, Wilson, J, Gao, G, Long, C, Remarque, E, Thomas, A, Ammendola, V, Colloca, S, Dicks, M, Biswas, S, Seibel, D, van Duivenvoorde, L, Gilbert, S, Hill, A, Draper, S

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES by Barnes, E, Antonella, F, Aston, S, Smith, K, Brown, A, Capone, S, Ambrosio, M, Harrison, G, Ammendola, V, Bartiromo, M, Traboni, C, Siani, L, Sparacino, A, Naddeo, M, Colloca, S, Cortese, R, Nicosia, A, Klenerman, P

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS by Barnes, E, Folgori, A, Capone, S, Aston, S, Meyer, J, Gantlett, K, Smith, K, Huddart, R, Brown, A, Kurioka, A, Humphreys, I, Harrison, G, Kelly, C, Ammendola, V, Colloca, S, Naddeo, M, Siani, L, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. by Rosario, M, Bridgeman, A, Quakkelaar, E, Quigley, M, Hill, B, Knudsen, M, Ammendola, V, Ljungberg, K, Borthwick, N, Im, E, Mcmichael, A, Drijfhout, J, Greenaway, H, Venturi, V, Douek, D, Colloca, S, Liljeström, P, Nicosia, A, Price, D, Melief, C, Hanke, T

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection by Swadling, L, Halliday, J, Kelly, C, Brown, A, Capone, S, Ansari, M, Bonsall, D, Richardson, R, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Von Delft, A, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P, Folgori, A, Barnes, E

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS by Kelly, C, Folgori, A, Capone, S, Stafford, E, O'Donnell, D, Gantlett, K, Collier, J, Brown, A, Huddart, R, Humphreys, I, Kurioka, A, Townsend, R, Swadling, L, Ammendola, V, Colloca, S, Naddeo, M, Siani, L, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P, Barnes, E

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection by Swadling, L, Halliday, J, Kelly, C, Brown, A, Capone, S, Ansari, M, Bonsall, D, Richardson, R, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Von Delft, A, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P, Folgori, A, Barnes, E

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species. by Colloca, S, Barnes, E, Folgori, A, Ammendola, V, Capone, S, Cirillo, A, Siani, L, Naddeo, M, Grazioli, F, Esposito, M, Ambrosio, M, Sparacino, A, Bartiromo, M, Meola, A, Smith, K, Kurioka, A, O'Hara, G, Ewer, K, Anagnostou, N, Bliss, C, Hill, A, Traboni, C, Klenerman, P, Cortese, R, Nicosia, A

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory by Swadling, L, Capone, S, Antrobus, R, Brown, A, Richardson, R, Newell, E, Halliday, J, Kelly, C, Bowen, D, Fergusson, J, Kurioka, A, Ammendola, V, Del Sorbo, M, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Hill, A, Colloca, S, Davis, M, Nicosia, A, Cortese, R, Folgori, A, Klenerman, P, Barnes, E

Hepatitis Hide and Seek by Barnes, E, Folgori, A, Capone, S, Swadling, L, Aston, S, Kurioka, A, Meyer, J, Huddart, R, Smith, K, Townsend, R, Brown, A, Antrobus, R, Ammendola, V, Naddeo, M, O'Hara, G, Willberg, C, Harrison, A, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Oo, Y, Adams, D, Hill, A, Colloca, S

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans by Kelly, C, Swadling, L, Capone, S, Brown, A, Richardson, R, Halliday, J, von Delft, A, Oo, Y, Mutimer, D, Kurioka, A, Hartnell, F, Collier, J, Ammendola, V, Sorbo, M, Grazioli, F, Esposito, M, Marco, S, Siani, L, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Folgori, A, Klenerman, P, Barnes, E

Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans. by Kelly, C, Swadling, L, Capone, S, Brown, A, Richardson, R, Halliday, J, von Delft, A, Oo, Y, Mutimer, D, Kurioka, A, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Grazioli, F, Luisa Esposito, M, Di Marco, S, Siani, L, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Folgori, A, Klenerman, P, Barnes, E

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man by Barnes, E, Folgori, A, Capone, S, Swadling, L, Aston, S, Kurioka, A, Meyer, J, Huddart, R, Smith, K, Townsend, R, Brown, A, Antrobus, R, Ammendola, V, Naddeo, M, O'Hara, G, Willberg, C, Harrison, A, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Oo, Y, Adams, D, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans by Esposito, I, Cicconi, P, D'Alise, AM, Brown, A, Esposito, M, Swadling, L, Holst, PJ, Bassi, MR, Stornaiuolo, M, Mori, F, Vassilev, V, Li, W, Donnison, T, Gentile, C, Turner, B, von Delft, A, Del Sorbo, M, Barra, F, Contino, AM, Abbate, A, Novellino, E, Thomsen, AR, Christensen, JP, Lahm, A, Grazioli, F, Ammendola, V, Siani, L, Colloca, S, Klenerman, P, Nicosia, A, Dorrell, L, Folgori, A, Capone, S, Barnes, E